NFKB1 and breast cancer: Our present results showed that tectochrysin further inhibited TRAIL-inactivated NF-κB activity, as well as expression of p50 and p-IκB in HT-29 (resistant colon cancer cell), A549 (resistant lung cancer cell) and MCF-7 (resistant breast cancer cell).